| Moffitt

Can Adding Immunotherapy to Chemo Benefit More Cervical Cancer Patients?

Phase 3 trial results suggest adding pembrolizumab to chemotherapy improved survival for those with advanced or recurrent disease

Comparing Therapy Options for Melanoma In-Transit Metastases

New retrospective study is first direct comparison of first-line treatment

Ramping Up the Immune System to Fight Breast Cancer

Clinical trial led by Moffitt evaluates combination immunotherapy for HER2 positive metastatic disease

Moffitt Scientists Share Innovative Clinical Research at ASCO

The American Society of Clinical Oncology Annual Meeting attracts more than 40,000

Hematologist Trains at Moffitt, Hoping to Benefit Armenians

Through a visiting physician program, a doctor is learning the intricacies of an allogeneic BMT procedure and care to help his home country

Combo Therapy for Advanced Endometrial Cancer Improves Cancer Free Survival

Study shows adding immunotherapy to treatment reduces risk of recurrence by up to 70%

Proper Oral Care for Cancer Patients Reduces Infections

Blood and marrow transplant and cellular immunotherapy patients have better comfort and outcomes, new research shows

Moffitt Bringing Proton Therapy Treatment Facility to Speros FL

The addition follows a $15 million contribution from the Schulze Family Foundation

High School Biology Lesson Inspires Decades-long Career as Bone Marrow Transplanter

Dr. Lia Perez is a hematologist and researcher who is an expert in allogeneic hematopoietic stem cell transplantation

What Are Bispecific Antibodies?

Novel cancer immunotherapy has made remarkable progress in the past decade

Lung Cancer Screening Saves Lives

Less than 6% of eligible Americans receive the screening

CAR T Puts Moffitt Patient in an Exclusive Club

Approximately 100 multiple myeloma patients at Moffitt have been treated with new immunotherapy

Study Highlights Potential Disparities for CAR T Patients with Multiple Myeloma

Hispanics had lower response rates

New Immunotherapy Could Be on the Horizon for Ovarian Cancer

Understanding tertiary lymphoid structures could unlock new treatments for a variety of cancers

Cellular Therapy May Be Viable Option for Advanced Melanoma Patients

Nearly one-third of patients respond to a single infusion of tumor infiltrating lymphocytes

What are Biomarkers?

Dr. Patrick Hwu tackles the question in this episode of the Moffitt Medical Minute

World-Renowned Trumpeter Finds Hope in Merkel Cell Carcinoma Clinical Trial

Vince DiMartino has had a robust response rate to the combination treatment of two immunotherapy drugs

Moffitt Cancer Center’s Clinical Trials Focus on Expansion, Diversity and Innovation

The cancer center offers one of the largest portfolios of clinical trials in the nation, with nearly 400 active treatment trials

What’s the Difference Between Chemotherapy and Immunotherapy?

Dr. Patrick Hwu tackles the question in this episode of the Moffitt Medical Minute

Autologous vs. Allogeneic CAR T

Dr. Patrick Hwu discusses the benefits of off-the-shelf CAR T

Does CAR T Show Promise for Solid Tumors?

Dr. Patrick Hwu tackles the topic in this episode of the Moffitt Medical Minute

Moffitt’s Newest Partnership to Advance Cell Therapies for Solid Tumors

Strategic alliance with Turnstone Biologics Corp. focuses on tumor infiltrating lymphocyte therapies

Can Gene-Edited CAR T Improve Non-Hodgkin Lymphoma Outcomes?

New product involves dual targeting, signaling technology and gene editing

Every Moment Matters: A Father’s Perspective

Melanoma survivor details juggling first-time fatherhood through cancer

Can the Gut Microbiome Predict Response to Cancer Treatment?

New study suggests so for recurrent metastatic head and neck cancer patients

Moffitt Researchers Use Explainable AI to Investigate and Predict the Survival Efficacy of Immunotherapy Drug

Data presented at ASCO help researchers get a deeper understanding of immune checkpoint inhibitors efficiency in patients

How Can We Improve Our Immune Response to Cancer?

Dr. Patrick Hwu discusses Anti-PD-1 therapy in this episode of the Moffitt Medical Minute.

Can Viruses Be Used to Treat Cancer?

Dr. Patrick Hwu tackles the answer in this Moffitt Medical Minute

UltraCAR-T™ Shows Promise for Treating Myeloid Malignancies

Fast-acting treatment aims to extend lives when minutes matter

Moffitt Study Shows Benefit to Giving CAR T-cell Therapy to Patients Sooner

Using cell therapy as a second-line treatment provided better outcomes for lymphoma patients compared to standard of care

Does Intensifying Lymphodepletion Impact CAR T-Cell Therapy?

Study investigates increasing duration and dosage of chemotherapy in patients with B-cell malignancies

Identifying Enhanced Response to Immunotherapy in Melanoma

New studies show gender and cancer origin can affect how well patients respond to treatment

Can Tumor Mutations Cause Resistance to Cellular Immunotherapy?

Moffitt study shows certain alterations can indicate poor outcomes for lymphoma patients receiving CAR T-cell therapy

Can Your Microbiome Impact Cancer?

Dr. Patrick Hwu tackles the answer in this Moffitt Medical Minute.

Immunotherapy Benefits Older Patients as Much as Younger Patients

New study favors expanding use of immunotherapy in older patients

FDA Approves 1st CAR T Therapy for Adults with Acute Lymphoblastic Leukemia

Twelve years and two relapses later, Branden Akens says optimism and a clinical trial helped him start his next chapter

Do You Know the Facts About Sarcoma?

The rare, but treatable, type of cancer affects thousands of Floridians

New Donor Cell Transplant Treatment Shows Promise in Multiple Myeloma

Allogeneic hematopoietic cell transplantation can extend survival for patient when combined with chemotherapy

‘Off the Shelf’ CAR T Shows Promise

New study results find the therapy is effective for certain lymphoma patients

Combo of Three Therapies Shows Promise for Advanced Melanoma

Triplet therapy offers hope for stage 4 melanoma patients including those with brain metastases

Moffitt Celebrates Cell Therapy Milestone

The cancer center infused its 500th patient with CAR T-cell therapy

Moffitt Names Researcher of the Year

The 2020 W. Jackson Pledger Researcher of the Year is Dr. José Conejo-Garcia

Aggressively Facing Advanced Melanoma

Patient Goes for Experimental TIL Therapy

Expanding CAR T to Adults with Acute Lymphoblastic Leukemia

New study results show cellular therapy could be an option for older patient population

Following the Science

Five of 10 researchers from MD Anderson joined Dr. Patrick Hwu at Moffitt

Moffitt CEO Focuses Research on Creating ‘Super Soldiers’

Hwu’s lab seeks out new T-cell therapies for some of the toughest cancers

FDA Approves First Immunotherapy for Initial Treatment of Gastric Cancer

Nivolumab combined with chemotherapy led to a 29% reduced risk of death

Immunotherapy Makes Big Strides in Esophageal Cancer

Immune-boosting drugs show promise in multiple different trials

Bladder Preservation Therapy Offers Choice to Patients

Bladder removal is a common treatment for an aggressive form of the disease

FDA Approves CAR T to Help Patients with Relapsed Multiple Myeloma

For one patient, the therapy, made available to him through a clinical trial, was his last resort

Immunology Offers Hope for Melanoma Patients

Novel agents train immune cells

New CAR T Therapy Tested for Multiple Myeloma

The cellular targets the B-cell maturation antigen found on malignant plasma cells

Once a Fighter, Always a Fighter

Former prosecutor battles stage 4 lung cancer with help of investigational immunotherapy

‘Jeopardy!’ Host Alex Trebek Dies at 80

Longtime game show host was diagnosed with stage 4 pancreatic cancer in 2019

What’s Next in Cellular Immunotherapy?

Five Questions with Dr. Frederick Locke

Head and Neck Cancer Patients Report Fatigue, Insomnia from Immunotherapy

Cognitive behavior intervention may help treatment side effects

Harnessing the Immune System to Treat Head and Neck Cancer

Moffitt study shows adoptive cell therapy could be an option

Rethinking Cellular Immunotherapy

Moffitt study uses CAR T therapy to treat side effects of cancer therapy

New Immunotherapy for Advanced Melanoma

Lifileucel offers hope for metastatic melanoma patients who fail approved treatment

Speeding Up Cellular Immunotherapy

New ‘off the shelf’ CAR T product shows promise in phase 1 study

Can Immunotherapy Treat HIV-Positive Cancer Patients?

Recent studies show the treatment could be offered soon

Neutralizing COVID-19

An immunotherapy used to treat cancer may help fight the coronavirus

Melanoma Immunotherapy Offers Hope for Lung Cancer

Patients’ own magnified army of T cells used to treat non-small cell lung cancer

An Immunotherapy Used to Treat Cancer May Help COVID-19 Patients

FDA approves clinical trials using cellular immunotherapy to battle the virus

New Moffitt Unit is Completely Dedicated to Immune Cell Therapy

The state-of-the-art ICE-T unit will give patients and their caregivers a better treatment experience

Accidental Discovery Could Lead to Future Cancer Therapy

Researchers in Europe discover T cell that may help detect and kill several cancers

Bridging Therapy Not Recommended for All CAR T Patients

New data presented by Moffitt shows poorer outcome for patients who receive bridging therapy prior to CAR T-cell therapy.

Lumpectomy vs. Mastectomy

Each surgical treatment for breast cancer has different benefits and risks.

Moffitt Announces Launch of Immunotherapy Contract Research Organization

The new organization will provide end-to-end services for pharmaceutical and biotech companies seeking to accelerate research.

Moffitt Expands TIL Therapy Research

Young sarcoma patients may benefit from tumor infiltrating lymphocyte therapy.

The Power of CAR T in Solid Tumor Treatment

CAR T therapy involves a patient’s own T cells that have been genetically engineered to target a patient’s own specific cancer.

Moffitt Research Moves New Immunotherapy Closer to FDA Approval

Some cancer patients may be one step closer to being treated with cells from their own tumors.

CAR T Therapy Safe for Older Patients

Moffitt’s closer look at clinical trial data could expand therapy’s use and effectiveness.

Treating Gynecologic Cancers With Immunotherapy

Physicians and researchers are combining efforts to explore ways to harness the body’s immune system to better fight gynecologic cancers.

Immunotherapy May Boost Survival in Recurrent Ovarian Cancer

Combination chemotherapy and immunotherapy treatment shows promise in recent study.

FDA Approves First Immunotherapy for Breast Cancer

Patients with an aggressive form of breast cancer now have another weapon in their arsenal to fight the disease.

The Monkees’ Peter Tork Had Rare Tongue Cancer

The Monkees’ bassist passed away this week. He also had a rare form of tongue cancer.

New Study Shows CAR T-cell Therapy for Lymphoma Lives up to its Press

Seventeen cancer centers compare real world outcomes of diffuse large B cell lymphoma patients treated with Yescarta® to ZUMA-1 clinical trial data

Is Immunotherapy the Key to Fighting Ovarian Cancer?

Oncologists believe immunotherapy could be the missing piece of the puzzle.

Moffitt Uses Innovative Immunotherapy to Stand Up To (Lung) Cancer

The unique clinical trial combining two immunotherapies is funding by the Stand Up To Cancer Catalyst® Program.

A New Drug Could Soon Be Available to Treat a Common Form of Skin Cancer

Nearly half of the patients who participated in the trial saw their tumors shrink.

Small Cell Lung Cancer Patients Who Have Failed Previous Therapies Now Have New Hope — the First in 20 Years

New drug allows your T cells to go to work, destroying cancer.

CAR T Drives New Ovarian Cancer Research

The new genetically-modified CAR T-cells seek out and destroy cancer cells expressing an FSH receptor protein found on a large number of ovarian cance ...

CAR T Provides Remission, Purpose for Moffitt Leukemia Patient

For CAR T treatment, T cells are removed from a patient’s blood and sent to a lab where the cells are genetically modified to better enable them to id ...

FDA Approves Second CAR T Therapy for Diffuse Large B-Cell Lymphoma

Moffitt Cancer Center is the only center in Florida to offer both FDA approved CAR T therapies, Kymriah™ and Yescarta™

Ovarian Cancer Patients May Benefit from Personalized Vaccines

Could personalized vaccines be the future of ovarian cancer treatment?

Immunotherapy Key to Unlocking Lung Cancer Survival

A recent study represents another step forward in immunotherapy, which has been making steady gains in recent years.

Third Grade Friends Hold Bake Sale to Raise Money for Cancer Research

The two students mailed a handwritten note to Dr. Frederick Locke, the CAR T investigator at Moffitt, to "use the money we made at our bake sale to he ...

Filter Features Results

88 Articles Found